EIKELBOOM, J.W., S.J. CONNOLLY, J. BOSCH, G.R. DAGENAIS, R.G. HART, O. SHESTAKOVSKA, R. DIAZ, M. ALINGS, E.M. LONN, S.S. ANAND, P. WIDIMSKY, M. HORI, A. AVEZUM, L.S. PIEGAS, K.R.H. BRANCH, J. PROBSTFIELD, D.L. BHATT, J. ZHU, Y. LIANG, A.P. MAGGIONI, P. LOPEZ-JARAMILLO, M. O´DONNELL, A.K. KAKKAR, K.A.A. FOX, A.N. PARKHOMENKO, G. ERTL, S. STORK, M. KELTAI, L. RYDEN, N. POGOSOVA, A.L. DANS, F. LANAS, P.J. COMMERFORD, C. TORP-PEDERSEN, T.J. GUZIK, P.B. VERHAMME, D. VINEREANU, J.H. KIM, A.M. TONKIN, B.S. LEWIS, C. FELIX, K. YUSOFF, P.G. STEG, K.P. METSARINNE, N.C. BRUNS, F. MISSELWITZ, E. CHEN, D. LEONG a S. YUSUF. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2017, roč. 377, č. 14, s. 1319-1330. ISSN 0028-4793. Dostupné z: https://dx.doi.org/10.1056/NEJMoa1709118.